Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Animals : an Open Access Journal From MDPI|June 2, 2021
Detection of Beta-Lactam-Resistant Escherichia coli and Toxigenic Clostridioides difficile Strains in Wild Boars Foraging in an Anthropization GradientLaila Darwich, Chiara Seminati, Jorge R López-Olvera, et al.
Acta Haematologica|November 17, 2012
Refining the diagnosis and prognostic categorization of acute myeloid leukemia patients with an integrated use of cytogenetic and molecular studiesDolors Costa, Anna Vidal, Ana Carrió, et al.
Nefrologia|April 13, 2024
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratioAnna Vidal-Alabró, Helena Colom, Pere Fontova, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 25, 2026
Incidence and survival of epithelial salivary glands cancer by tumor site and histology in Tarragona and Girona, Catalonia, SpainJordi Rubió-Casadevall, Jan Trallero, Montserrat Puigdemont, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 4, 2018
ANRIL as a genetic marker for cardiovascular events in renal transplant patients - an observational follow-up cohort studyAriadna Arbiol-Roca, Ariadna Padró-Miquel, Anna Vidal-Alabró, et al.
Lung Cancer (Amsterdam, Netherlands)|October 24, 2024
Lung cancer survival trends and prognostic factors: A 26-year population-based study in Girona Province, SpainEduard Teixidor-Vilà, Jan Trallero, Montse Puigdemont, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2014
Disruption of follicular dendritic cells-follicular lymphoma cross-talk by the pan-PI3K inhibitor BKM120 (Buparlisib)Alba Matas-Céspedes, Vanina Rodriguez, Susana G Kalko, et al.
Frontiers in Pharmacology|October 4, 2024
Guiding the starting dose of the once-daily formulation of tacrolimus in "de novo" adult renal transplant patients: a population approachBeatriz Fernández-Alarcón, Oscar Nolberger, Anna Vidal-Alabró, et al.
Molecular Cancer|November 1, 2024
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironmentChristina Sternberg, Martin Raigel, Tanja Limberger, et al.
Frontiers in Pharmacology|April 5, 2021
Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney TransplantationPere Fontova, Helena Colom, Raül Rigo-Bonnin, et al.
Pageof 9